PatientsVille.com Logo

Doxorubicin Side Effects

PatientsVille

Common Doxorubicin Side Effects


The most commonly reported Doxorubicin side effects (click to view or check a box to report):

Febrile Neutropenia (280)
Neutropenia (241)
Pyrexia (216)
Off Label Use (185)
Anaemia (173)
Nausea (146)
Diarrhoea (144)
Pneumonia (133)
Dyspnoea (129)
Interstitial Lung Disease (120)
Vomiting (116)
White Blood Cell Count Decreased (110)
Ovarian Cancer (110)
Sepsis (102)
Palmar-plantar Erythrodysaesthesia Syndrome (100)
Abdominal Pain (95)
Pneumocystis Jiroveci Pneumonia (94)
Platelet Count Decreased (91)
Fatigue (91)
Mucosal Inflammation (83)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Doxorubicin Side Effects Reported to FDA



Doxorubicin Side Effect Report#9999032
Pulmonary Infarction, Klebsiella Infection, Vasospasm, Toxicity To Various Agents
This is a report of a 76-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: hepatocellular carcinoma, who was treated with Doxorubicin (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Pulmonary Infarction, Klebsiella Infection, Vasospasm, Toxicity To Various Agents after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Doxorubicin treatment in male patients, resulting in Pulmonary Infarction side effect. The patient was hospitalized.
Doxorubicin Side Effect Report#9997292
Acute Myeloid Leukaemia, Myelodysplastic Syndrome, Pancytopenia
This report suggests a potential Doxorubicine Acute Myeloid Leukaemia side effect(s) that can have serious consequences. A 60-year-old male patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: hodgkin^s disease stage iii and used Doxorubicine (dosage: NA) starting
Feb 09, 1999. After starting Doxorubicine the patient began experiencing various side effects, including: Acute Myeloid Leukaemia, Myelodysplastic Syndrome, PancytopeniaAdditional drugs used concurrently:
  • Caryolysine 10mg (9 Milligram Daily;)
  • Velbe 10mg
  • Bleomycine Bellon 15mg
  • Etoposide Merck 10mg (100 Milligram Daily;)
  • Eldisine 10mg
The patient was hospitalized. Although Doxorubicine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Acute Myeloid Leukaemia, may still occur.
Doxorubicin Side Effect Report#9997291
Cardiac Failure, Cardiomyopathy, Pulmonary Hypertension
This Cardiac Failure problem was reported by a health professional from FR. A 18-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: synovial sarcoma. On 200805 this consumer started treatment with Doxorubicine Teva (dosage: NA). The following drugs were being taken at the same time:
  • Gardasil
When using Doxorubicine Teva, the patient experienced the following unwanted symptoms/side effects: Cardiac Failure, Cardiomyopathy, Pulmonary HypertensionThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Cardiac Failure, may become evident only after a product is in use by the general population.
Doxorubicin Side Effect Report#9994708
Deep Vein Thrombosis, Pulmonary Embolism, Cardiomyopathy, Staphylococcal Bacteraemia, Skin Exfoliation, Radiation Injury, Ischaemic Cardiomyopathy
This Deep Vein Thrombosis side effect was reported by a physician from US. A 78-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Doxorubicin Hydrochloride (drug dosage: NA), which was initiated on NS. Concurrently used drugs: NA..After starting to take Doxorubicin Hydrochloride the consumer reported adverse symptoms, such as: Deep Vein Thrombosis, Pulmonary Embolism, Cardiomyopathy, Staphylococcal Bacteraemia, Skin Exfoliation, Radiation Injury, Ischaemic CardiomyopathyThese side effects may potentially be related to Doxorubicin Hydrochloride. The patient was hospitalized.
Doxorubicin Side Effect Report#9993298
Pulmonary Infarction, Klebsiella Infection
This is a report of a 76-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: hepatocellular carcinoma, who was treated with Doxorubicin (dosage: Embolic Material Preloaded With Doxorubicin 50mg, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Pulmonary Infarction, Klebsiella Infection after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Doxorubicin treatment in male patients, resulting in Pulmonary Infarction side effect.
Doxorubicin Side Effect Report#9992356
Skin Toxicity
This report suggests a potential Doxorubicin Hydrochloride (caelyx) Skin Toxicity side effect(s) that can have serious consequences. A 50-year-old female patient (weight: NA) from IT was diagnosed with the following symptoms/conditions: breast cancer and used Doxorubicin Hydrochloride (caelyx) (dosage: 2 Mg/ml) starting
May 09, 2013. After starting Doxorubicin Hydrochloride (caelyx) the patient began experiencing various side effects, including: Skin ToxicityAdditional drugs used concurrently: NA. Although Doxorubicin Hydrochloride (caelyx) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Skin Toxicity, may still occur.
Doxorubicin Side Effect Report#9989022
Pulmonary Infarction
This Pulmonary Infarction problem was reported by a physician from US. A 76-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: hepatocellular carcinoma. On NS this consumer started treatment with Doxorubicin Hydrochloride Injection 2mg/ml (dosage: 50 Mg, Unk). The following drugs were being taken at the same time: NA. When using Doxorubicin Hydrochloride Injection 2mg/ml, the patient experienced the following unwanted symptoms/side effects: Pulmonary InfarctionThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Pulmonary Infarction, may become evident only after a product is in use by the general population.
Doxorubicin Side Effect Report#9981422
Skin Disorder, Off Label Use
This Skin Disorder side effect was reported by a health professional from AT. A female patient (weight:NA) experienced the following symptoms/conditions: uterine leiomyosarcoma.The patient was prescribed Doxorubicin Hydrochloride (caelyx) (drug dosage: 50 Mg/m2), which was initiated on
Dec 05, 2013. Concurrently used drugs:
  • Amlodipine
  • Emend (Once In The Evening)
  • Neulasta
  • Remistat (In The Evening)
.After starting to take Doxorubicin Hydrochloride (caelyx) the consumer reported adverse symptoms, such as: Skin Disorder, Off Label UseThese side effects may potentially be related to Doxorubicin Hydrochloride (caelyx).
Doxorubicin Side Effect Report#9954412
Pulmonary Infarction, Pulmonary Embolism, Klebsiella Infection, Pyrexia, Sputum Discoloured, Rhonchi, Lung Infiltration
This is a report of a 76-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: hepatocellular carcinoma, who was treated with Doxorubicin (dosage: 50 Mg, Unk, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Pulmonary Infarction, Pulmonary Embolism, Klebsiella Infection, Pyrexia, Sputum Discoloured, Rhonchi, Lung Infiltration after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Doxorubicin treatment in male patients, resulting in Pulmonary Infarction side effect. The patient was hospitalized.
Doxorubicin Side Effect Report#9942215
Pulmonary Fibrosis, Aspergillus Infection, Hypoventilation, Respiratory Acidosis, Haemodynamic Instability, Pneumocystis Jirovecii Pneumonia, Acute Respiratory Failure, Pneumonia Cytomegaloviral
This report suggests a potential Doxorubicine Teva 50mg/25ml Pulmonary Fibrosis side effect(s) that can have serious consequences. A 36-year-old male patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: b-cell lymphoma and used Doxorubicine Teva 50mg/25ml (dosage: 600 Mg In 4 Courses) starting
May 30, 2007. After starting Doxorubicine Teva 50mg/25ml the patient began experiencing various side effects, including: Pulmonary Fibrosis, Aspergillus Infection, Hypoventilation, Respiratory Acidosis, Haemodynamic Instability, Pneumocystis Jirovecii Pneumonia, Acute Respiratory Failure, Pneumonia CytomegaloviralAdditional drugs used concurrently:
  • Bleomycine Bellon 15mg (80 Mg In 4 Courses)
  • Mabthera 500mg Concentrado Para Solucion Para Perfusion, 1 Vial De 50m (4500mg In 6 Courses)
  • Endoxan 1000mg (9600mg In 4 Courses)
  • Eldisine (32 Mg In 4 Courses)
  • Methotrexate Merck (11970 Mg In 2 Courses)
  • Etopophos For Inj 100 Mg (1200mg In 2 Courses)
  • Holoxan 3.00 G (6000mg In 2 Courses)
  • Bicnu (600 Milligram Daily;)
The patient was hospitalized and became disabled. Although Doxorubicine Teva 50mg/25ml demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Pulmonary Fibrosis, may still occur.
Doxorubicin Side Effect Report#9941447
Respiratory Distress, Arrhythmia Supraventricular
This Respiratory Distress problem was reported by a health professional from FR. A 53-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Aug 24, 2010 this consumer started treatment with Doxorubicine Teva (dosage: 106 Milligram Daily;). The following drugs were being taken at the same time:
  • Holoxan (4000 Milligram Daily;)
When using Doxorubicine Teva, the patient experienced the following unwanted symptoms/side effects: Respiratory Distress, Arrhythmia SupraventricularThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Respiratory Distress, may become evident only after a product is in use by the general population.
Doxorubicin Side Effect Report#9937247
Syncope, Neutropenia, Thrombocytopenia
This Syncope side effect was reported by a health professional from US. A 71-year-old male patient (weight:NA) experienced the following symptoms/conditions: sarcoma metastatic.The patient was prescribed Doxorubicin (drug dosage: NA), which was initiated on
Oct 01, 2013. Concurrently used drugs: NA..After starting to take Doxorubicin the consumer reported adverse symptoms, such as: Syncope, Neutropenia, ThrombocytopeniaThese side effects may potentially be related to Doxorubicin. The patient was hospitalized.
Doxorubicin Side Effect Report#9935174
Mantle Cell Lymphoma, Small Intestinal Obstruction, Peritonitis, Clostridium Difficile Infection, Streptococcal Infection, Septic Shock, Abdominal Abscess, Off Label Use
This is a report of a 57-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: mantle cell lymphoma, who was treated with Doxorubicin (dosage: NA, start time: NS), combined with:
  • Bendamustine
  • Rituximab
  • Cyclophosphamide
  • Vincristine
  • Prednisone
  • Bortezomib
and developed a serious reaction and side effect(s): Mantle Cell Lymphoma, Small Intestinal Obstruction, Peritonitis, Clostridium Difficile Infection, Streptococcal Infection, Septic Shock, Abdominal Abscess, Off Label Use after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Doxorubicin treatment in male patients, resulting in Mantle Cell Lymphoma side effect. The patient was hospitalized.
Doxorubicin Side Effect Report#9935005
Acute Myeloid Leukaemia, Myelodysplastic Syndrome, Thrombocytopenia, Off Label Use
This report suggests a potential Doxorubicin Acute Myeloid Leukaemia side effect(s) that can have serious consequences. A 5-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: neuroblastoma and used Doxorubicin (dosage: 6 Cycles. Cumulative Dosage Was 300 Mg/m^2) starting NS. After starting Doxorubicin the patient began experiencing various side effects, including: Acute Myeloid Leukaemia, Myelodysplastic Syndrome, Thrombocytopenia, Off Label UseAdditional drugs used concurrently:
  • Cyclophosphamide (Cumulative Dosage Was 16,800 Mg/m^2)
  • Vincristine
  • Cisplatin (Cumulative Dosage Was 400 Mg/m^2)
  • Etoposide (Cumulative Dosage Was 1200 Mg/m^2)
Although Doxorubicin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Acute Myeloid Leukaemia, may still occur.
Doxorubicin Side Effect Report#9935003
Myelodysplastic Syndrome, Off Label Use
This Myelodysplastic Syndrome problem was reported by a physician from US. A 5-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: neuroblastoma. On NS this consumer started treatment with Doxorubicin (dosage: Cumulative Dosage Was 225 Mg/m^2). The following drugs were being taken at the same time:
  • Cyclophosphamide (Cumulative Dosage Was 12,600 Mg/m^2)
  • Cisplatin (Cumulative Dosage Was 400 Mg/m^2)
  • Etoposide (Cumulative Dosage Was 1200 Mg/m^2)
When using Doxorubicin, the patient experienced the following unwanted symptoms/side effects: Myelodysplastic Syndrome, Off Label UseAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Myelodysplastic Syndrome, may become evident only after a product is in use by the general population.
Doxorubicin Side Effect Report#9931704
Acute Febrile Neutrophilic Dermatosis, Myelodysplastic Syndrome, Off Label Use
This Acute Febrile Neutrophilic Dermatosis side effect was reported by a physician from US. A 8-year-old female patient (weight:NA) experienced the following symptoms/conditions: neuroblastoma.The patient was prescribed Doxorubicin (drug dosage: Cumulative Dosage Was 300 Mg/m^2), which was initiated on NS. Concurrently used drugs:
  • Cyclophosphamide (Cumulative Dosage Was 16,800 Mg/m^2)
  • Vincristine (Cycles 1, 2, 4, 6, And 8)
  • Cisplatin (Cumulative Dosage Was 600 Mg/m^2)
  • Etoposide (Cumulative Dosage Was 1800 Mg/m^2)
.After starting to take Doxorubicin the consumer reported adverse symptoms, such as: Acute Febrile Neutrophilic Dermatosis, Myelodysplastic Syndrome, Off Label UseThese side effects may potentially be related to Doxorubicin.
Doxorubicin Side Effect Report#9929492
Hepatic Failure, Hepatic Function Abnormal, Transaminases Increased, Hepatitis B, Decreased Appetite, Pyrexia, Vertigo
This is a report of a 68-year-old female patient (weight: NA) from JP, suffering from the following health symptoms/conditions: NA, who was treated with Doxorubicin (dosage: 50 Mg/m2, Unk, start time: NS), combined with:
  • 5-fluorouracil (500 Mg/m2, Unk)
  • Cyclophosphamide (500 Mg/m2)
and developed a serious reaction and side effect(s): Hepatic Failure, Hepatic Function Abnormal, Transaminases Increased, Hepatitis B, Decreased Appetite, Pyrexia, Vertigo after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Doxorubicin treatment in female patients, resulting in Hepatic Failure side effect. The patient was hospitalized.
Doxorubicin Side Effect Report#9926126
Fatigue, Supraventricular Tachycardia, Dehydration
This report suggests a potential Doxorubicin Hcl Fatigue side effect(s) that can have serious consequences. A 78-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: sarcoma metastatic and used Doxorubicin Hcl (dosage: Cyclic) starting
Aug 09, 2013. After starting Doxorubicin Hcl the patient began experiencing various side effects, including: Fatigue, Supraventricular Tachycardia, DehydrationAdditional drugs used concurrently: NA.The patient was hospitalized. Although Doxorubicin Hcl demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Fatigue, may still occur.
Doxorubicin Side Effect Report#9926125
Urinary Tract Infection
This Urinary Tract Infection problem was reported by a physician from US. A 78-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: sarcoma metastatic. On
Jun 21, 2013 this consumer started treatment with Doxorubicin Hcl (dosage: Unk). The following drugs were being taken at the same time: NA. When using Doxorubicin Hcl, the patient experienced the following unwanted symptoms/side effects: Urinary Tract InfectionThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Urinary Tract Infection, may become evident only after a product is in use by the general population.
Doxorubicin Side Effect Report#9926120
Syncope, Neutropenia, Thrombocytopenia
This Syncope side effect was reported by a physician from US. A 71-year-old male patient (weight:NA) experienced the following symptoms/conditions: leiomyosarcoma metastatic.The patient was prescribed Doxorubicin Hcl (drug dosage: 37.5 Mg/m2, Cyclic), which was initiated on
Oct 01, 2013. Concurrently used drugs: NA..After starting to take Doxorubicin Hcl the consumer reported adverse symptoms, such as: Syncope, Neutropenia, ThrombocytopeniaThese side effects may potentially be related to Doxorubicin Hcl. The patient was hospitalized.
Doxorubicin Side Effect Report#9924678
Neuroblastoma, Myelodysplastic Syndrome, Off Label Use
This is a report of a 25-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: neuroblastoma, who was treated with Doxorubicin Hydrochloride (dosage: Cumulative Dosage Was 300 Mg/m2, start time: NS), combined with:
  • Cyclophosphamide (Cumulative Dosage Was 16,800 Mg/m2)
  • Cisplatin (Cumulative Dosage Was 600 Mg/m2)
  • Etoposide (Cumulative Dosage Was 1800 Mg/m2)
  • Vincristine
and developed a serious reaction and side effect(s): Neuroblastoma, Myelodysplastic Syndrome, Off Label Use after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Doxorubicin Hydrochloride treatment in female patients, resulting in Neuroblastoma side effect.
Doxorubicin Side Effect Report#9924677
Thrombocytopenia, Myelodysplastic Syndrome, Off Label Use
This report suggests a potential Doxorubicin Hydrochloride Thrombocytopenia side effect(s) that can have serious consequences. A 3-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: neuroblastoma and used Doxorubicin Hydrochloride (dosage: Cumulative Dosage Was 300 Mg/m2) starting NS. After starting Doxorubicin Hydrochloride the patient began experiencing various side effects, including: Thrombocytopenia, Myelodysplastic Syndrome, Off Label UseAdditional drugs used concurrently:
  • Cyclophosphamide (Cumulative Dosage Was 16,800 Mg/m2)
  • Cisplatin (Cumulative Dosage Was 600 Mg/m2)
  • Etoposide (Cumulative Dosage Was 1800 Mg/m2)
  • Vincristine
Although Doxorubicin Hydrochloride demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Thrombocytopenia, may still occur.
Doxorubicin Side Effect Report#9924676
Lymphoproliferative Disorder, Off Label Use
This Lymphoproliferative Disorder problem was reported by a physician from US. A 3-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: neuroblastoma. On NS this consumer started treatment with Doxorubicin (dosage: Cycles 1, 2, 4, 6, 8). The following drugs were being taken at the same time:
  • Cyclophosphamide (Cycles 1, 2, 4, 6, 8)
  • Vincristine (Cycles 1, 2, 4, 6, 8)
  • Cisplatin (Cycles 3, 5, 7)
  • Etoposide (Cycles 3, 5, 7)
When using Doxorubicin, the patient experienced the following unwanted symptoms/side effects: Lymphoproliferative Disorder, Off Label UseAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Lymphoproliferative Disorder, may become evident only after a product is in use by the general population.
Doxorubicin Side Effect Report#9924675
Toxicity To Various Agents, Acute Lymphocytic Leukaemia, Off Label Use
This Toxicity To Various Agents side effect was reported by a physician from US. A 3-year-old male patient (weight:NA) experienced the following symptoms/conditions: neuroblastoma.The patient was prescribed Doxorubicin (drug dosage: Cumulative Dosage Was 300 Mg/m2), which was initiated on NS. Concurrently used drugs:
  • Cyclophosphamide (Cumulative Dosage Was 16,800 Mg/m2)
  • Cisplatin (Cumulative Dosage Was 600 Mg/m2)
  • Etoposide (Cumulative Dosage Was 1800 Mg/m2)
.After starting to take Doxorubicin the consumer reported adverse symptoms, such as: Toxicity To Various Agents, Acute Lymphocytic Leukaemia, Off Label UseThese side effects may potentially be related to Doxorubicin.
Doxorubicin Side Effect Report#9924673
Leukaemia, Monocytosis, Off Label Use
This is a report of a 12-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: neuroblastoma, who was treated with Doxorubicin Hydrochloride (dosage: NA, start time: NS), combined with:
  • Cyclophosphamide
  • Cisplatin
  • Etoposide
  • Vincristine
and developed a serious reaction and side effect(s): Leukaemia, Monocytosis, Off Label Use after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Doxorubicin Hydrochloride treatment in male patients, resulting in Leukaemia side effect.


1 of 152 


The appearance of Doxorubicin on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

What are common Doxorubicin Side Effects for Women?

Women Side EffectsReports
Febrile Neutropenia 172
Neutropenia 146
Pyrexia 138
Anaemia 125
Nausea 125
Ovarian Cancer 110
Interstitial Lung Disease 92
Vomiting 91
Diarrhoea 89
Dyspnoea 85

What are common Doxorubicin Side Effects for Men?

Men Side EffectsReports
Febrile Neutropenia 106
Off Label Use 95
Neutropenia 89
Pyrexia 76
Pneumonia 63
Diarrhoea 54
Anaemia 48
Dyspnoea 44
Thrombocytopenia 42
Sepsis 38

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Doxorubicin reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Doxorubicin Side Effects

    Did You Have a Doxorubicin Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Doxorubicin for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Doxorubicin Safety Alerts, Active Ingredients, Usage Information

    NDC0069-0170
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameDoxorubicin Hydrochloride
    NameDoxorubicin Hydrochloride
    Dosage FormINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    RouteINTRAVENOUS
    On market since20111029
    LabelerPfizer Laboratories Div Pfizer Inc.
    Active Ingredient(s)DOXORUBICIN HYDROCHLORIDE
    Strength(s)2
    Unit(s)mg/mL
    Pharma ClassAnthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhib

    More About Doxorubicin

    Side Effects reported to FDA: 3782

    Doxorubicin safety alerts: No

    Reported deaths: 583

    Reported hospitalizations: 1392

    Latest Doxorubicin clinical trials

    Doxorubicin Reviews

    No reviews, be a first to report a side effect via side effect reporting form